Search for publications

Search results

4364 items matching your search terms.

Association of baseline and change in tibial and femoral cartilage thickness and development of widespread full-thickness cartilage loss in knee osteoarthritis - data from the Osteoarthritis Initiative

Dorio, M. Hunter, D. J. Collins, J. E. Asher, R. Eckstein, F. Guermazi, A. Roemer, F. W. Deveza, L. A.
OSTEOARTHRITIS AND CARTILAGE, 2020     DOI:10.1016/j.joca.2020.03.011

Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial

Frumovitz, M. Obermair, A. Coleman, R. L. Pareja, R. Lopez, A. Ribero, R. Isla, D. Rendon, G. Bernadini, M. Q. Buda, A. Moretti-Marquez, R. Zevallos, A. Vieira, M. A. Zhu, T. Land, R. P. Nicklin, J. Asher, R. Robledo, K. P. Gebski, V. Ramirez, P. T.
LANCET ONCOLOGY, 2020     DOI:10.1016/S1470-2045(20)30081-4

Questioning statin therapy for older patients - Authors' reply

Fulcher, J. Keech, A. Simes, J. Baigent, C. Collins, R.
LANCET, 2020     DOI:10.1016/S0140-6736(19)33159-9

Second-line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real-world eligibility for cabozantinib, regorafenib, and ramucirumab

Fung, A. S. Tam, V. C. Meyers, D. E. Sim, H. W. Knox, J. J. Zaborska, V. Davies, J. Ko, Y. J. Batuyong, E. Samawi, H. Cheung, W. Y. Lee-Ying, R.
CANCER MED, 2020     DOI:10.1002/cam4.3116

Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): A pragmatic, open-label, 12-month, randomised controlled trial

Furler, J. O'Neal, D. Speight, J. Blackberry, I. Manski-Nankervis, J. A. Thuraisingam, S. de La Rue, K. Ginnivan, L. Doyle, R. Holmes-Truscott, E. Khunti, K. Dalziel, K. Chiang, J. Audehm, R. Kennedy, M. Clark, M. Jenkins, A. Lake, A. J. Januszewski, A. S. Catchpool, M. Liew, D. Clarke, P. Best, J.
LANCET DIABETES ENDOCRINOL, 2020     DOI:10.1016/S2213-8587(19)30385-7

Cognition after lowering LDL-cholesterol with evolocumab

Gencer, B. Mach, F. Guo, J. Im, K. Ruzza, A. Wang, H. Kurtz, C. E. Pedersen, T. R. Keech, A. C. Ott, B. R. Sabatine, M. S. Giugliano, R. P. Fourier Investigators
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020     DOI:10.1016/j.jacc.2020.03.039

Efficacy of evolocumab on cardiovascular outcomes in patients with recent myocardial infarction: A prespecified secondary analysis from the FOURIER trial

Gencer, B. Mach, F. Murphy, S. A. De Ferrari, G. M. Huber, K. Lewis, B. S. Ferreira, J. Kurtz, C. E. Wang, H. Honarpour, N. Keech, A. C. Sever, P. S. Pedersen, T. R. Sabatine, M. S. Giugliano, R. P.
JAMA CARDIOL, 2020     DOI:10.1001/jamacardio.2020.0882

Stroke prevention with the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) inhibitor evolocumab added to statin in high-risk patients with stable atherosclerosis

Giugliano, R. P. Pedersen, T. R. Saver, J. L. Sever, P. S. Keech, A. C. Bohula, E. A. Murphy, S. A. Wasserman, S. M. Honarpour, N. Wang, H. Lira Pineda, A. Sabatine, M. S. Fourier Investigators
STROKE, 2020     DOI:10.1161/STROKEAHA.119.027759

Nomogram for estimating overall survival in patients with metastatic pancreatic cancer

Goldstein, D. Von Hoff, D. D. Chiorean, E. G. Reni, M. Tabernero, J. Ramanathan, R. K. Botteman, M. Aly, A. Margunato-Debay, S. Lu, B. Louis, C. U. McGovern, D. Lee, C. K.
PANCREAS, 2020     DOI:10.1097/MPA.0000000000001563

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

Grimison, P. Mersiades, A. Kirby, A. Lintzeris, N. Morton, R. Haber, P. Olver, I. Walsh, A. McGregor, I. Cheung, Y. Tognela, A. Hahn, C. Briscoe, K. Aghmesheh, M. Fox, P. Abdi, E. Clarke, S. Della-Fiorentina, S. Shannon, J. Gedye, C. Begbie, S. Simes, J. Stockler, M.
ANNALS OF ONCOLOGY, 2020     DOI:10.1016/j.annonc.2020.07.020

Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE Head and Neck study

Grunwald, V. Chirovsky, D. Cheung, W. Y. Bertolini, F. Ahn, M. J. Yang, M. H. Castro, G. Berrocal, A. Sjoquist, K. Kuyas, H. Auclair, V. Guillaume, X. Joo, S. Shah, R. Harrington, K. Glance Head and Neck Study Investigators
ORAL ONCOLOGY, 2020     DOI:10.1016/j.oraloncology.2019.104526

A comprehensive proteomic SWATH-MS workflow for profiling blood extracellular vesicles: a new avenue for glioma tumour surveillance

Hallal, S. Azimi, A. Wei, H. Ho, N. Lee, M. Y. T. Sim, H. W. Sy, J. Shivalingam, B. Buckland, M. E. Alexander-Kaufman, K. L.

Deep sequencing of small RNAs from Neurosurgical extracellular vesicles substantiates miR-486-3p as a circulating biomarker that distinguishes glioblastoma from lower-grade astrocytoma patients

Hallal, S. Ebrahim Khani, S. Wei, H. Lee, M. Y. T. Sim, H. W. Sy, J. Shivalingam, B. Buckland, M. E. Alexander-Kaufman, K. L.

Adults with diabetes distress often want to talk with their health professionals about it: Findings from an audit of four Australian specialist diabetes clinics

Hendrieckx, C. Halliday, J. A. Russell-Green, S. Cohen, N. Colman, P. G. Jenkins, A. O'Neal, D. Speight, J.
CAN J DIABETES, 2020     DOI:10.1016/j.jcjd.2020.02.004

Survivorship care plans in cancer: A meta-analysis and systematic review of care plan outcomes

Hill, R. E. Wakefield, C. E. Cohn, R. J. Fardell, J. E. Brierley, M. E. Kothe, E. Jacobsen, P. B. Hetherington, K. Mercieca-Bebber, R.
ONCOLOGIST, 2020     DOI:10.1634/theoncologist.2019-0184